Pharmaceutical News

RSS

Court approves Abbott settlement for wrongly marketing Depakote

The pharmaceutical company will pay $1.5 billion for marketing the drug for non-approved uses.

4 Oct 2012

New type of drug for drug-resistant cancer

New drug may be an effective alternative for patients whose cancer is resistant to currently available drugs.

4 Oct 2012

Bristol-Myers Squibb, Sanofi restructure long-term alliance

Sanofi and Bristol-Myers Squibb Company today announced they have restructured their successful long-term alliance following the loss of exclusivity of Plavix and Avapro/Avalide in many major markets.

4 Oct 2012

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

XBiotech, a privately held biotechnology company, announced today that the company has been granted Fast Track designation for its anti-cachexia drug Xilonix.

4 Oct 2012

Gateway Foundation to raise awareness of synthetic drug use

In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.

4 Oct 2012

Treatment with Lfcin4-14 reduces DNA damage in colon cancer cells exposed to UV light

Milk consumption has been linked to improved health, with decreased risks of diabetes, metabolic syndrome, and colon cancer. A group of scientists in Sweden found that lactoferricin4-14 (Lfcin4-14), a milk protein with known health effects, significantly reduces the growth rate of colon cancer cells over time by prolonging the period of the cell cycle before chromosomes are replicated. In a new study, investigators report that treatment with Lfcin4-14 reduced DNA damage in colon cancer cells exposed to ultraviolet (UV) light.

4 Oct 2012

Starting HIV-infected patients on ART reduces food insecurity, improves physical health

Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.

4 Oct 2012

LpxC-1 can effectively treat antibiotic-resistant infections

A new type of antibiotic can effectively treat an antibiotic-resistant infection by disarming instead of killing the bacteria that cause it. Researchers report their findings in the October 2 issue of mBio-, the online open-access journal of the American Society for Microbiology.

3 Oct 2012

Two court cases could affect medicines patent law in India

In the PLoS "Speaking of Medicine" blog, Leena Menghaney, a lawyer and India manager of the Access Campaign at Medecins Sans Frontieres, writes about "two critical legal battles between multinational pharmaceutical companies and the Indian government that are taking center stage in an ongoing struggle over India's medicines patent law."

3 Oct 2012

Beta-blockers do not appear to reduce risk of cardiovascular events in patients with CAD

Among patients with either coronary artery disease (CAD) risk factors only, known prior heart attack, or known CAD without heart attack, the use of beta-blockers was not associated with a lower risk of a composite of cardiovascular events that included cardiovascular death, nonfatal heart attack or nonfatal stroke, according to a study in the October 3 issue of JAMA.

3 Oct 2012

Financial Times examines legal disputes in India over pharmaceutical patent laws

The Financial Times reports on a legal dispute between the Indian government and the German pharmaceutical group Bayer, writing, "Bayer is appealing against the Indian patent controller's decision in March to override the company's monopoly on its cancer drug Nexavar, and to allow an Indian company to produce and sell the life-extending drug for just $173 a month -- one-sixth of the $5,500 a month price charged by Bayer."

3 Oct 2012

Synthetic hybrid molecules more effectively tackle chemo-resistant cancers

When Linda Tuttle was diagnosed with breast cancer, she never imagined her experience would inspire her colleagues to design new treatments to tackle the disease.

3 Oct 2012

Chloroquine begins to work against malaria

Malaria-drug monitoring over the past 30 years has shown that malaria parasites develop resistance to medicine, and the first signs of resistance to the newest drugs have just been observed. At the same time, resistance monitoring at the University of Copenhagen shows that the previously efficacious drug chloroquine is once again beginning to work against malaria. In time that will ensure cheaper treatment for the world's poor.

3 Oct 2012

Fluoxetine increases offensive aggression and alters brain development in adolescent hamsters

Fluoxetine was the first drug approved by the FDA for major depressive disorder (MDD) in children and adolescents, and to this date, it remains one of only two selective serotonin reuptake inhibitors (SSRIs) registered for treatment of MDD in children and adolescents, despite reports that indicate this class of drugs is associated with side effects, such as agitation, hostility and aggression.

3 Oct 2012

CINJ database enhancements help physicians to ensure safety in chemotherapy delivery

Database enhancements developed at The Cancer Institute of New Jersey (CINJ) are helping physicians use technology to further ensure safety in the delivery of chemotherapy.

3 Oct 2012

InterMune receives Health Canada approval for Esbriet to treat idiopathic pulmonary fibrosis

InterMune, Inc. today announced that Health Canada has approved Esbriet (pirfenidone) for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) in adult patients.

3 Oct 2012

October issue of WHO Bulletin available online

The October issue of the WHO Bulletin features an editorial on the stockpiling oral cholera vaccine, a public health news roundup, a research article on rotavirus mortality in India, and an article examining a "new entity for the negotiation of public procurement prices for patented medicines in Mexico," among others.

2 Oct 2012

Paroxetine shows promise against heart failure

A medication usually used to help treat depression and anxiety disorders has the potential to help prevent heart failure, according to researchers at the University of Michigan.

2 Oct 2012

Proton pump inhibitors does not lead to higher rates of pneumonia

Previous studies that have associated the use of proton pump inhibitors (PPI) - which include popular anti-heartburn medications like Prilosec and Nexium - with an increased incidence of pneumonia may not have found a true cause-and-effect relationship.

2 Oct 2012

Statins may protect against glaucoma

People who take statins to reduce their risk of cardiovascular disease are less likely to be diagnosed with the most common form of glaucoma, according to a nationwide study of more than 300,000 patients.

2 Oct 2012

Pharmaceutical News

Court approves Abbott settlement for wrongly marketing Depakote

New type of drug for drug-resistant cancer

Bristol-Myers Squibb, Sanofi restructure long-term alliance

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

Gateway Foundation to raise awareness of synthetic drug use

Treatment with Lfcin4-14 reduces DNA damage in colon cancer cells exposed to UV light

Starting HIV-infected patients on ART reduces food insecurity, improves physical health

LpxC-1 can effectively treat antibiotic-resistant infections

Two court cases could affect medicines patent law in India

Beta-blockers do not appear to reduce risk of cardiovascular events in patients with CAD

Financial Times examines legal disputes in India over pharmaceutical patent laws

Synthetic hybrid molecules more effectively tackle chemo-resistant cancers

Chloroquine begins to work against malaria

Fluoxetine increases offensive aggression and alters brain development in adolescent hamsters

CINJ database enhancements help physicians to ensure safety in chemotherapy delivery

InterMune receives Health Canada approval for Esbriet to treat idiopathic pulmonary fibrosis

October issue of WHO Bulletin available online

Paroxetine shows promise against heart failure

Proton pump inhibitors does not lead to higher rates of pneumonia

Statins may protect against glaucoma

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News